Beijing Tong Ren Tang Chinese Medicine Co., Ltd. Cash Flow Statement: Consolidated Financial Analysis & Historical Data (15 Years)

Cash Flow

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. Cash flow Statement

Figures in Million

Consolidated Cash Flow Results

Dec'25

Dec'24

Dec'23

Dec'22

Dec'21

Dec'20

No of Months

Profit Before Tax

513.00

627.00

691.00

827.00

778.00

686.00

Adjustment

0.00

Changes In working Capital

269.00

-774.00

-34.00

-326.00

60.00

-421.00

Cash Flow after changes in Working Capital

0.00

Cash Flow from Operating Activities

868.00

-157.00

524.00

557.00

777.00

140.00

Cash Flow from Investing Activities

-37.00

1,310.00

-1,147.00

320.00

-270.00

477.00

Cash Flow from Financing Activities

-381.00

-370.00

-366.00

-530.00

-274.00

-259.00

Net Cash Inflow / Outflow

454.00

773.00

-991.00

330.00

234.00

369.00

Opening Cash & Cash Equivalents

0.00

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

Effect of Foreign Exchange Fluctuations

5.00

-9.00

-1.00

-16.00

1.00

10.00

Closing Cash & Cash Equivalent

0.00

Figures in HKD Million
Seasonal companies are compared with the same quarter last year

Compare Cash Flow Results of Beijing Tong Ren Tang Chinese Medicine Co., Ltd.

Select Peers

Figures in Million

consolidated Cash Flow Results

Change(HKD)

Change(%)

Profit Before Tax

513.414

10341.2897831282

-9,828.00

-95.04%

Adjustment

0.00

0.00%

Changes In working Capital

269.547

-4139.50413160743

4,408.00

106.51%

Cash Flow after changes in Working Capital

0.00

0.00%

Cash Flow from Operating Activities

868.234

7252.79416970547

-6,384.00

-88.03%

Cash Flow from Investing Activities

-37.732

-5029.94196923388

4,992.00

99.25%

Cash Flow from Financing Activities

-381.05

-5996.7729980839

5,615.00

93.65%

Net Cash Inflow / Outflow

454.773

-3777.29973769344

4,231.00

112.04%

Opening Cash & Cash Equivalents

0.00

0.00%

Cash & Cash Equivalent on Amalgamation / Take over / Merger

0.00

0.00%

Cash & Cash Equivalent of Subsidiaries under liquidations

0.00

0.00%

Translation adjustment on reserves / op cash balances foreign subsidiaries

0.00

0.00%

Effect of Foreign Exchange Fluctuations

5.321

-3.37894008113331

8.00

257.48%

Closing Cash & Cash Equivalent

0.00

0.00%

Cash Flow - Snapshot (Consolidated) - Dec'25

YoY Growth in year ended Dec 2025 is 649.79% vs -130.14% in Dec 2024

Dec'25

Dec'24

Change(%)

Cash Flow from Operating Activities

868.23

-157.92

649.79%